Attached files

file filename
10-K - 10-K - Evofem Biosciences, Inc.evfm-1231201910xk.htm
EX-32.1 - EXHIBIT 32.1 - Evofem Biosciences, Inc.evfm-12312019ex32110k.htm
EX-31.2 - EXHIBIT 31.2 - Evofem Biosciences, Inc.evfm-12312019ex31210k.htm
EX-31.1 - EXHIBIT 31.1 - Evofem Biosciences, Inc.evfm-12312019ex31110k.htm
EX-10.58 - EXHIBIT 10.58 - Evofem Biosciences, Inc.evfm-12312019ex105810k.htm
EX-4.15 - EXHIBIT 4.15 - Evofem Biosciences, Inc.evfm-12312019ex41510k.htm
Exhibit 23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-234769, 333-230191, 333-231126, 333-232303, and 333-223731 on Form S-3 and Registration Statement Nos. 333-231993, 333-231991, 333-226517, 333-225366, 333-203059, and 333-200409 on Form S-8 of our report dated March 12, 2020, relating to the financial statements of Evofem Biosciences, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2019.

/s/ DELOITTE & TOUCHE LLP
San Diego, California
March 12, 2020


1